Regulatory Challenges, Reimbursement, and Risk-Benefit Assessment

被引：14
|
作者：
Breckenridge, A. [1 ]
机构：
[1] Med & Healthcare Prod Regulatory Agcy, London, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 02期
关键词：
D O I：
10.1038/clpt.2010.76
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [1] Risk-benefit assessment of foods - status, challenges, and opportunities
    Thomsen, Sofie Theresa
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [2] Meeting the challenges in the development of risk-benefit assessment of foods
    Nauta, Maarten J.
    Andersen, Rikke
    Pilegaard, Kirsten
    Pires, Sara M.
    Ravn-Haren, Gitte
    Tetens, Inge
    Poulsen, Morten
    [J]. TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2018, 76 : 90 - 100
  • [3] Risk-Benefit Assessment of Foods
    Assuncao, R.
    Pires, S. M.
    Nauta, M.
    [J]. EFSA JOURNAL, 2019, 17
  • [4] A Risk-Benefit Assessment of Amifostine in Cytoprotection
    May Mabro
    Sandrine Faivre
    Eric Raymond
    [J]. Drug Safety, 1999, 21 : 367 - 387
  • [5] A Risk-Benefit Assessment of Antileukotrienes in Asthma
    Lewis J. Smith
    [J]. Drug Safety, 1998, 19 : 205 - 218
  • [6] A RISK-BENEFIT ASSESSMENT OF RISPERIDONE IN SCHIZOPHRENIA
    CURTIS, VA
    KERWIN, RW
    [J]. DRUG SAFETY, 1995, 12 (02) : 139 - 145
  • [7] Risk-benefit ratio or risk-benefit nonsense?
    Ernst, E
    Resch, KL
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (10) : 1203 - 1204
  • [8] A RISK-BENEFIT ASSESSMENT OF TAMOXIFEN THERAPY
    CATHERINO, WH
    JORDAN, VC
    [J]. DRUG SAFETY, 1993, 8 (05) : 381 - 397
  • [9] A risk-benefit assessment of abciximab in angioplasty
    Kleiman, NS
    [J]. DRUG SAFETY, 1999, 20 (01) : 43 - 57
  • [10] A RISK-BENEFIT ASSESSMENT OF TACROLIMUS IN TRANSPLANTATION
    WINKLER, M
    CHRISTIANS, U
    [J]. DRUG SAFETY, 1995, 12 (05) : 348 - 357
12345